Nuvig Therapeutics is a biotechnology company developing treatments for autoimmune diseases that do not rely on immunosuppression.

ShiraTronics develops a neuromodulation device for treating chronic migraine patients.

Odyssey Therapeutics is a biotech firm specializing in developing precision immunomodulators and oncology medicines, with plans to advance multiple therapeutic programs into clinical studies.

Acesion Pharma is a biotech company that develops therapies for atrial fibrillation, specifically focusing on the clinical development of an SK ion channel inhibitor for chronic oral treatment.